38892314|t|hTERT Peptide Fragment GV1001 Prevents the Development of Porphyromonas gingivalis-Induced Periodontal Disease and Systemic Disorders in ApoE-Deficient Mice.
38892314|a|GV1001, an anticancer vaccine, exhibits other biological functions, including anti-inflammatory and antioxidant activity. It also suppresses the development of ligature-induced periodontitis in mice. Porphyromonas gingivalis (Pg), a major human oral bacterium implicated in the development of periodontitis, is associated with various systemic disorders, such as atherosclerosis and Alzheimer's disease (AD). This study aimed to explore the protective effects of GV1001 against Pg-induced periodontal disease, atherosclerosis, and AD-like conditions in Apolipoprotein (ApoE)-deficient mice. GV1001 effectively mitigated the development of Pg-induced periodontal disease, atherosclerosis, and AD-like conditions by counteracting Pg-induced local and systemic inflammation, partly by inhibiting the accumulation of Pg DNA aggregates, Pg lipopolysaccharides (LPS), and gingipains in the gingival tissue, arterial wall, and brain. GV1001 attenuated the development of atherosclerosis by inhibiting vascular inflammation, lipid deposition in the arterial wall, endothelial to mesenchymal cell transition (EndMT), the expression of Cluster of Differentiation 47 (CD47) from arterial smooth muscle cells, and the formation of foam cells in mice with Pg-induced periodontal disease. GV1001 also suppressed the accumulation of AD biomarkers in the brains of mice with periodontal disease. Overall, these findings suggest that GV1001 holds promise as a preventive agent in the development of atherosclerosis and AD-like conditions associated with periodontal disease.
38892314	23	29	GV1001	Chemical	-
38892314	58	82	Porphyromonas gingivalis	Species	837
38892314	91	110	Periodontal Disease	Disease	MESH:D010510
38892314	115	133	Systemic Disorders	Disease	MESH:D009422
38892314	152	156	Mice	Species	10090
38892314	158	164	GV1001	Chemical	-
38892314	241	253	inflammatory	Disease	MESH:D007249
38892314	335	348	periodontitis	Disease	MESH:D010518
38892314	352	356	mice	Species	10090
38892314	358	382	Porphyromonas gingivalis	Species	837
38892314	384	386	Pg	Species	837
38892314	397	402	human	Species	9606
38892314	451	464	periodontitis	Disease	MESH:D010518
38892314	493	511	systemic disorders	Disease	MESH:D009422
38892314	521	536	atherosclerosis	Disease	MESH:D050197
38892314	541	560	Alzheimer's disease	Disease	MESH:D000544
38892314	562	564	AD	Disease	MESH:D000544
38892314	621	627	GV1001	Chemical	-
38892314	636	638	Pg	Species	837
38892314	647	666	periodontal disease	Disease	MESH:D010510
38892314	668	683	atherosclerosis	Disease	MESH:D050197
38892314	689	691	AD	Disease	MESH:D000544
38892314	743	747	mice	Species	10090
38892314	749	755	GV1001	Chemical	-
38892314	797	799	Pg	Species	837
38892314	808	827	periodontal disease	Disease	MESH:D010510
38892314	829	844	atherosclerosis	Disease	MESH:D050197
38892314	850	852	AD	Disease	MESH:D000544
38892314	886	888	Pg	Species	837
38892314	916	928	inflammation	Disease	MESH:D007249
38892314	971	973	Pg	Species	837
38892314	990	992	Pg	Species	837
38892314	993	1012	lipopolysaccharides	Chemical	MESH:D008070
38892314	1014	1017	LPS	Chemical	MESH:D008070
38892314	1085	1091	GV1001	Chemical	-
38892314	1122	1137	atherosclerosis	Disease	MESH:D050197
38892314	1152	1173	vascular inflammation	Disease	MESH:D007249
38892314	1175	1180	lipid	Chemical	MESH:D008055
38892314	1391	1395	mice	Species	10090
38892314	1401	1403	Pg	Species	837
38892314	1412	1431	periodontal disease	Disease	MESH:D010510
38892314	1433	1439	GV1001	Chemical	-
38892314	1476	1478	AD	Disease	MESH:D000544
38892314	1507	1511	mice	Species	10090
38892314	1517	1536	periodontal disease	Disease	MESH:D010510
38892314	1575	1581	GV1001	Chemical	-
38892314	1640	1655	atherosclerosis	Disease	MESH:D050197
38892314	1660	1662	AD	Disease	MESH:D000544
38892314	1695	1714	periodontal disease	Disease	MESH:D010510

